chief complaint: dysphagia. history of present illness 5 months pta experienced dysphagia and...
TRANSCRIPT
Chief Complaint: DYSPHAGIA
History of Present Illness
Jan.22- Feb.21EGD- circumferential, nodular, partially
obstructing and friable mass from 35 cm level of esophagus down to the cardia (41cm level)
Biopsy of esophageal mass- well differentiated squamous cell carcinoma
Biopsy of cardia of stomach esophageal mass- revealled esophageal mucosa with severe dysplasia can’t totally rule out invasive squamous cell carcinoma
Endoscopic guided insertion of NGT doneCT Scan of chest and upper abdomen= soft
tissue mass noted on the esophagus from the distal third up to the gastroesophageal junction causing significant narrowing of its lumen (1/26/09)
35th hospital day=started 1st cycle of radiotherapy and chemotherapy (cisplatin & 5-FU)
CT Scan of whole abdomen= circumferential wall thickening in the included distal esophagus and adjacent gastric cardia with thickness ranging from 7-16mm. A solitary lymphadenopathy is seen in the perigastroesophageal region measuring 1.8x1.4 cm. (4/18/09 other hospital)
CT Scan of the chest= esophageal new growth involving the middle and lower 3rd of portion with slight regression (5/6/09)
Past Medical History+ for Polio in 1958 at age 3+ for TB in 1980, 3 months treatment2002, laceration right upper quadrant,
sutured without any complicationsNo HPN, DM, allergies, Goiter and Asthma
Family History+ for colon cancer, sister+ asthma- siblings, mother, grandmother+ for DM- mother+ for PTB- father
Personal & Social History23 pack years of smoking, stopped 3 months
nowAlcoholic beverage drinker (brandy TID, 1
long neck for 23 years), stopped 5 months now
+ for substance use- tried few sessions of marijuana and shabu, but denied addiction
Review of Systems General: (‐) fever/ sweats/anorexia/ weakness HEENT: (‐) visual dysfunction/redness/ itchiness/ pain/ lacrimation, (‐) deafness/ Hnnitus/ discharge, (‐) bleeding gums/ sores/ fissures/tongue abnormalities/ dental caries, (‐) sore throat/ tonsillitis, (‐) stiffness/ limitation of motion/ masses/ adenopathy/ sensation of lump in the throat Pulmonary: (‐) dyspnea/ shortness of breath/ cough/ sputum production/ hemoptysis/ wheezing/ back pain/ chest wall abnormality Cardiac: (‐) chest pain/ easy fatigability/orthopnea/ nocturnal dyspnea/ palpitations/ syncope/edema/ HPN Vascular: (‐) phlebitis/ varicosities/ claudication Gastrointestinal: (‐) nausea/ vomiting/ GI bleeding/ flatulence Genito‐urinary: (‐) urinary frequency/ urgency/ hesitancy/ dysuria/ hematuria/ nocturia/ urine stream flow abnormality/ flank pain/ stones/urethral discharge/ genital lesions/testicular mass/ perineal pain/ impotence/ vaginal discharge/ abnormal bleeding Musculoskeletal: (‐) joint stiffness/ pain/ swelling/ muscle pain/ weakness Endocrine: (‐) heat‐cold intolerance/ thyroid problems/ polyuria polydipsia polyphagia Psychiatric: (‐) anxiety/ depression/ interpersonal relationship difficulties
Physical ExamBP (mm Hg): 90/60Pulse rate / character: 80bpm, regularRespiratory rate / pattern: 18cpm, regularTemperature (°C): 36.6°CWt. (kg.): 43.5Ht. (cm): 158.5BMI: 17.4
GENERAL SURVEY: conscious, coherent, ambulatory notcardio‐pulmonary distress
SKIN: warm, moist dry skin, no active dermatosesHEENT: pale palpebral conjunctiva, anicteric sclera,pupils 2‐3 mm round and ERTL No alar flaring, nonaso‐aural d/c. (+) NGT right Nostril. No impactedcerumen, intact tympanic bilateral membrane, nasalseptum midline, (‐) tenderness, inflammation (‐)bleeding, ecchymosis (‐) anosmia, (‐) facialasymmetry. Moist buccal mucosa, non‐hyperemic
NECK: supple neck, lymph nodes non‐palpable cervical LN
thyroid gland not enlarged, no other massesTHORAX / LUNGS: symmetrical chest expansion,
noretractions, no lagging, equal tactile fremiti,
resonantlung fields, breath sounds with expiratory wheeze
onboth upper lung fields more prominent rightCARDIOVASCULAR: adynamic precordium, AB
5th LICS MCL,S1>S2 apex, S2 > S1 at the base, no murmursAll pulses normal
ABDOMEN: scaphoid abdomen, (+) 6 cm diagonal scar at
RUQ, normoactive bowel sounds, tympanitic onpercussion, Traube’s space not obliterated, no
direct orrebound tenderness, spleen not palpable (‐) fluid
wave,(‐) CVA tendernessMUSCULOSKELETAL: Asymmetric lower
extremiHes (leIlonger and thinner than the right), (‐)
tenderness, (‐)swellingNEUROLOGIC EXAM: normal
Salient Features53 years oldMaleBMI: 17.4 (N: 18.5-23)Progressive dysphagia to solids and liquidsvomitingBody weakness(+) family history of colon CA23 smoking pack years, stopped 5 months agoAlcoholic
Brandy TID1 long neck for 23 years, stopped 5 months ago
(+) substance abuse: marijuana,shabu(-) lymphadenopathies(-)anorexia
Salient FeaturesEGD:
circumferential, nodular, partially obstructing and friable mass from 35cm level of esophagus down to the cardia (41cm level)
Biopsy of esophageal mass Squamous cell carcinoma well differentiated.
Biopsy of cardia of stomach esophageal massRevealed esophageal mucosa with severe dysplasia
cannot totally rule out invasive squamous cell cacinoma (well differentiated)
Endoscopic guided insertion of NGT CT Scan of chest & upper abdomen
soft tissue mass noted in the esophagus from the distal third up to the gastroesophageal junction causing significant narrowing of its lumen
Salient FeaturesCT scan of whole abdomen
circumferential wall thickening in the included distal esophagus and adjacent gastric cardia, with thickness ranging from 7‐16 mm. A solitary lymphadenopathy is seen in the perigastroesophageal region measuring 1.8 x 1.4 cm.
CT scan of chest esophageal new growth involving the middle
and lower third of portion with slight regression
Esophageal Cancer(Squamous Cell Ca)
Dysphagia• Difficulty in swallowing, the primary symptom of
esophageal disorders.• Sensation of sticking or obstruction of the
passage of food through the mouth, pharynx, or esophagus
Harrison’s Principles of Internal Medicine 17th ed. pp 237-239
DysphagiaMechanical due to large bolus or narrow
lumenMotor due to weakness of peristaltic
contractions or impaired deglutitive inhibition causing nonperistaltic contractions and impaired sphincter relaxation
Harrison’s Principles of Internal Medicine 17th ed. pp 237-239
Harrison’s Principles of Internal Medicine 17th ed. pp 237-239
Harrison’s Principles of Internal Medicine 17th ed. pp 237-239
Esophageal DysphagiaNormally can be distended up to 4cm in
diameterDysphagia to solid food <2.5cmDysphagia to fluids <1.3cm
Harrison’s Principles of Internal Medicine, 17th ed.
Squamous Cell Carcinoma of the EsophagusMost common type of carcinoma of the
esophagus – 90% Age > 50Most symptomatic tumors are quite large by
the time they are diagnosed and have already invaded the wall or beyond
20% -upper third, 50% - middle third, and 30% - lower third of the esophagus
Robbins and Cotran Pathologic Basis of Disease, 7th ed.
Squamous Cell Carcinoma of the EsophagusMost squamous cell carcinomas are
moderately to well differentiatedRich lymphatic network in the sub mucosa
promotes extensive circumferential and longitudinal spread
Areas of metastasisupper third - cervical lymph nodesmiddle third - mediastinal, paratracheal, and
tracheobronchial nodeslower third - gastric and celiac groups of nodes
Robbins and Cotran Pathologic Basis of Disease, 7th ed.
Pathogenesis of Esophageal Carcinoma
Injury
Stratified squamous Epithelium
Cell Death
Hyperplasia
Gastric Metaplasia
Inflammation
Dysplasia
CarcinomaGlandular Dysplasia
Adenocarcinoma
Ulcer
Pathogenesis of Squamous Cell Carcinoma
Injury
Stratified squamous Epithelium
Cell Death
Hyperplasia
Inflammation
Dysplasia
CarcinomaSquamous Cell
Carcinoma
Ulcer
p53 gene mutation
Clinical FeaturesInsidious in onset Produces dysphagia and obstruction
gradually and latePatient progressively alters their diet from
solid to liquid foodsExtreme weight lossDebilitation
Risk FactorsAlcohol consumption increases the risk of
squamous cell cancer 10 to 25 timesCombined cigarette use and alcohol
consumption can increase the risk of squamous cell cancer up to 100-fold
Ingestion of nitrosaminesContamination of food by specific fungiTemperature of ingested fluids Presence of mechanical irritants to the
esophagusSilicaCrushed seeds
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Chronic injury to the esophagus due to:Caustic ingestionStasis of foodstuffs in patients with achalasiaGastroesophageal acid reflux disease
Familial abnormality that is associated with squamous cancer of the esophagusTylosis A, which carries a 25 percent lifetime
risk.
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Enzinger et al NEJM 2003
DIAGNOSTIC TOOLSOBJECTIVE: To identify and locate the problem, as well as determine the extent of the diseasE
1.) CBC, PT/APTT, Electrolytes, TPAG
2.)12 lead ECG
3.)Spirometry
4.)Chest Xray
5.)CT scan
CBC - may show anemia secondary to iron deficiency or chronic disease.
PT and aPTT - may demonstrate hepatic insufficiency or nutritional deficiencies; also detects abnormalities in blood clotting
Electrolytes – should be obtained to determine imbalances, changes in fluid volume occur pre-op, intra op and post op
Spirometry - measures lung function, specifically the measurement of the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled.
12 lead ECG – a non invasive device that records electrical activity of the heart as well as detects possible abnormalities
Chest X-ray – to determine the condition of the heart and other adjacent structures.
CT scans - best tool for staging; to exclude the presence of metastases (M staging) to the lungs and liver; determines if adjacent structures have been invaded.
(Enzinger et al NEJM 2003)
Esophageal Cancer6th most frequent tumor disease worldwideCharacterized by rapid development and fatal
prognosis in most casesOccurrence increases with age with the
highest incidence in the age group 50–70 years
The disease is diagnosed more frequently in males than in females (3:5)
Most frequent histological type is squamous cell carcinomaEPIDEMIOLOGY OF ESOPHAGEAL CANCER – AN OVERVIEW ARTICLE
Department of Preventive Medicine, Faculty of Medicine, Palacky University Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech Republic
Helena Kollarova et al; March 29, 2007;
IncidenceEsophageal cancer incidence worldwide
462 117 in the year 2002 315 394 cases were diagnosed in males 146 723 cases in females
In males, the incidence is approximately three times higher than in females.
EPIDEMIOLOGY OF ESOPHAGEAL CANCER – AN OVERVIEW ARTICLE Department of Preventive Medicine, Faculty of Medicine, Palacky University Olomouc, Hnevotinska 3, 775
15 Olomouc, Czech Republic Helena Kollarova et al; March 29, 2007;
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
MortalityMortality rates represent roughly 90 % of the incidence
rates of the disease.
EPIDEMIOLOGY OF ESOPHAGEAL CANCER – AN OVERVIEW ARTICLE Department of Preventive Medicine, Faculty of Medicine, Palacky University Olomouc, Hnevotinska 3, 775
15 Olomouc, Czech Republic Helena Kollarova et al; March 29, 2007;
Philippines: Mortality 1998Male 252 per 100 000 (0.7%)Females 139 per 100 000 (0.4%)
from WHO www.who.int; 1998
Squamous Cell CarcinomaSquamous cell cancers represent the single
most common malignancy of the esophagus worldwide.Endemic areas for squamous cell cancer of the
esophagus Northern littoral in Iran Linxian, China Regions of South Africa, where the incidences are
as high as 150 cases per 100,000 population.
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
In the United StatesIncidence rate of squamous cell cancers is
about 3 per 100,000 population, Mortality: 12,000 deaths from squamous cell
esophageal cancer in 1998.Men are more commonly affected than are
womenHighest incidence occurs during the sixth
through eighth decades of life
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
Cancer of the Upper Gastrointestinal Tract by Posner et. al., November 2001
ComplicationsWeight LossNutritional DeficienciesDysphagiaSolid food impaction
Severe stenosisRequires endoscopic intervention for disimpaction.
Regurgitation of food or oral secretions Significant luminal obstruction
Halitosis Food stasisRegurgitation
American Medical Network: Esophageal Cancer; James C. Chou et.al
Pulmonary complications from aspiration PneumoniaPulmonary abscess
The tumor mass Compression Obstruction of the tracheobronchial tree
Leading to dyspnea, chronic cough, and at times postobstructive pneumonia.
Esophagoairway fistula may develop with tumor invasion of the trachea or bronchus. Airway fistulas are severely debilitating and
are associated with significant mortality owing to the high risk of pulmonary complications such as pneumonia and abscess.
TREATMENT
1. Surgical Management (curative)Treatment of Choice for early cancerprimary goal is complete resection of tumor and involved
lymph nodesanyone with disease up to T3 N1must be used with other management to improve survivalesophagectomy: approaches include transthoracic,
transhiatal, transoral routeRadical Resection - Surgical resection that takes the blood
supply and lymph system supplying the organ along with the organ.
thorascopic tools, laparoscopic toolsgastric/colonic mobilization
Radiation TherapyThe medical use of ionizing radiation as part of cancer
treatment to control malignant cells Radiotherapy may be used for curative or adjuvant
cancer treatment May be used as the primary therapy. Radiation therapy works by damaging the DNA of
cells. The damage is caused by a photon, electron, proton,
neutron, or ion beam directly or indirectly ionizing the atoms which make up the DNA chain
ChemotherapyTreatment of cancer through ChemicalsRefers to antineoplastic drugs used to treat cancer or
the combination of these drugs into a cytotoxic standardized treatment regimen.
Chemotherapy acts by killing cells that divide rapidly, one of the main properties of cancer cells.
Most chemotherapeutic drugs work by impairing mitosis
It also harms cells that divide rapidly under normal circumstances which results in the most common side-effects of chemotherapy.
Some drugs cause cells to undergo apoptosis or programmed cell death
2. RADIATION & CHEMOTHERAPY
CURABLE DISEASECombined is superior to radiation aloneAchieved overall survival rates that equal or
exceed those of historical surgical cohorts (though no trials comparing them)
Cisplatin and fluorouracil
Radiation with chemotherapy75% local control rate : improve swallowing30% actuarial disease free survival rate18% overall survival rateHigh Morbidity from adverse effects
3. Neoadjuvant therapyPreoperative radiation and chemotherapy then
resection
PALLIATIVE THERAPYMost patient with esophageal cancer have
advanced stage at time of initial medical consultation
<20% survive in 1st yearGoal of Palliation:
improvement of dysphagiaPain Management
PALLIATIVE THERAPYDISPLACEMENT
THERAPY
Dilation therapyStenting
ABLATIVE THERAPY
Contact thermalNoncontact ThermalCytotoxic injectionPhotodynamic therapies
PALLIATIVE THERAPYBleeding and esophageal fistula are the most
common adverse effectsNo improvement of pain and anorexia
Esophageal stent placement can well manage fistulas from primary malignancy
Enteral NutritionEnteral feeding when feasible
Attempt to improve functional status before and after surgery, during chemoradiation
Oral route: precluded by anorexia, gastric dysmotility, and generalized debilitation
Surgical jejunostomy
PrognosisThe prognosis of esophageal cancer is
generally unfavorable.Long-term survival is only approximately 5 %
of patients.Of patients who undergo radical
esophagectomies,10–20 % survive 5 years. In patients with inoperable cancer, the median
survival is 13–29 months.
EPIDEMIOLOGY OF ESOPHAGEAL CANCER – AN OVERVIEW ARTICLE Department of Preventive Medicine, Faculty of Medicine, Palacky University Olomouc, Hnevotinska 3, 775
15 Olomouc, Czech Republic Helena Kollarova et al; March 29, 2007;